fluoropyrimidine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
fluoropyrimidine
May 21, 2024, 15:36 |
Blog
To test or not to test this should be patient's decision - Advocates for Universal DPD/DPYD Testing
Advocates for Universal DPD/DPYD Testing shared a post by Ken Surprenanton, Advocate at DPD/DPYD, on…
May 1, 2024, 04:54 |
Blog
Howard McLeod: Preemptive DPYD Testing Program for patients planned for a systemic Fluoropyrimidine
Howard McLeod, Central Director, Founder and Advisor at Precision Medicine, shared on LinkedIn: “The USA…
Apr 11, 2024, 15:23 |
Drugs
Piotr Wysocki: Adagrasib and cetuximab in KRAS G12C-mutated colorectal cancer is a safe and active
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 8, 2024, 12:20 |
Insight
Smitha Krishnamurthi: Neoadjuvant chemo (NAC) has benefit in OPTICAL and FOxTROT!
Smitha Krishnamurthi, Gastrointestinal Medical Oncologist at Cleveland Clinic, shared on X/Twitter: "Neoadjuvant chemo (NAC) has…
Nov 1, 2023, 18:31 |
Drugs
David Sebag-Montefiore: We strongly caution against the use of FOLFOX alone applied to the whole PROSPECT trial population
David Sebag-Montefiore shared on LinkedIn: "Delighted to see our letter published in the New England Journal…
All:
5
Posts:
1 - 10
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube